Fate Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Fate Therapeutics stock have an average target of 5.43, with a low estimate of 3.00 and a high estimate of 9.00. The average target predicts an increase of 384.82% from the current stock price of 1.12.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$3.00	$5.43	$5.00	$9.00
Change	+167.86%	+384.82%	+346.43%	+703.57%

* Price targets were last updated on Mar 6, 2025.

Analyst Ratings

The average analyst rating for Fate Therapeutics stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	2	2	2	2	1	1
Buy	2	2	2	2	1	1
Hold	6	6	6	6	6	6
Sell	1	1	1	1	1	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	9	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Benjamin Burnett Stifel	Stifel	Hold Maintains $5 → $3	Hold	Maintains	$5 → $3	+167.86%	Mar 6, 2025
David Nierengarten Wedbush	Wedbush	Hold Reiterates $5	Hold	Reiterates	$5	+346.43%	Mar 6, 2025
Yanan Zhu Wells Fargo	Wells Fargo	Hold Maintains $5 → $4	Hold	Maintains	$5 → $4	+257.14%	Mar 6, 2025
Gil Blum Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 6, 2025
Gil Blum Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Nov 19, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

4.54M

from 13.63M

-66.69%

from 13.63M

Revenue Next Year

3.50M

from 4.54M

-22.90%

from 4.54M

EPS This Year

-1.58

from -1.64

EPS Next Year

-1.44

from -1.58

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	31.43M	55.85M	96.30M	63.53M	13.63M	4.54M	3.50M	3.78M
Revenue Growth	194.33%	77.66%	72.44%	-34.03%	-78.55%	-66.69%	-22.90%	7.94%
EPS	-2.10	-2.24	-2.91	-1.64	-1.64	-1.58	-1.44	-1.19
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	17	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	14.3M	14.3M	14.3M
Avg	4.5M	3.5M	3.8M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	4.8%	214.5%	307.9%
Avg	-66.7%	-22.9%	7.9%
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.13	-0.77	-0.55
Avg	-1.58	-1.44	-1.19
Low	-1.76	-2.01	-2.16

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.